Next Article in Journal
Surface Transmission or Polarized Egress? Lessons Learned from HTLV Cell-to-Cell Transmission
Next Article in Special Issue
The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials
Previous Article in Journal
A Host of Factors Regulating Influenza Virus Replication
Previous Article in Special Issue
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(2), 574-600;

CCR5: From Natural Resistance to a New Anti-HIV Strategy

Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, via Stamira D’Ancona, 20, 20127 Milan, Italy
Received: 23 October 2009 / Revised: 22 December 2009 / Accepted: 4 February 2010 / Published: 5 February 2010
(This article belongs to the Special Issue AIDS Vaccine)
PDF [834 KB, uploaded 12 May 2015]


The C-C chemokine receptor type 5 (CCR5) is a key player in HIV infection due to its major involvement in the infection process. Investigations into the role of the CCR5 coreceptor first focused on its binding to the virus and the molecular mechanisms leading to the entry and spread of HIV. The identification of naturally occurring CCR5 mutations has allowed scientists to address the CCR5 molecule as a promising target to prevent or limit HIV infection in vivo. Naturally occurring CCR5-specific antibodies have been found in exposed but uninfected people, and in a subset of HIV seropositive people who show long-term control of the infection. This suggests that natural autoimmunity to the CCR5 coreceptor exists and may play a role in HIV control. Such natural immunity has prompted strategies aimed at achieving anti-HIV humoral responses through CCR5 targeting, which will be described here. View Full-Text
Keywords: CCR5; HIV; vaccine CCR5; HIV; vaccine

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Lopalco, L. CCR5: From Natural Resistance to a New Anti-HIV Strategy. Viruses 2010, 2, 574-600.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top